Fig. 4From: Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumoniaAntibacterial response signaling pathway: antimicrobial peptides (a) and genes involved in the inflammatory response (b) at baseline as well as at days 3, 5 and 21 in children with community-acquired pneumonia (CAP) treated with antibiotics plus pidotimod and in controls treated with antibiotics onlyBack to article page